Assessment of MRI Tractography for Pelvic Floor Sphincter Analysis
NCT ID: NCT03881436
Last Updated: 2022-03-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
23 participants
INTERVENTIONAL
2019-08-12
2021-08-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
MRI tractography could be an interesting tool to visualize in 3D the structure of pelvic sphincters and their lesions. It may thereby establish the link with observed dysfunctions, thus potentially providing a complement to the urological and proctographic examinations already carried out.
The objective of this study is, first, to define the sensitivity of the MRI tractography for the visualization of the pelvic sphincters architecture regardless of the gender. In a second time, it will give a description of normal and abnormal (pathological cases) tractography, as well as a descriptive post-surgery. The other interest of this study is the assessment of the information provided by pelvic sphincters tractography on a panel of various and frequently encountered situations in clinical routine at the IHU.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Transperineal US on Basis of MRI in Female Pelvic Floor Dysfunction
NCT03456310
Study of the Nervous Control of the Anal Sphincter
NCT00213356
Trans-perineal Ultrasound & Dynamic Pelvic Magnetic Resonance Imaging in Assessment of Pelvic Floor Dysfunction.
NCT03241836
Descriptive and Prospective Study of Sphincter Disorders in the Severe Traumatic Brain Injury Population
NCT05163262
Cross-sectional Area of Pubovisceral Muscle in Nulliparous and Primiparous Women
NCT05800678
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In case of dysfunction, the sphincters can be scanned by imaging, including MRI, to assess the thickness or detect the presence of scars. The current MRI examinations in clinical routine are not capable to characterize the complex architecture of these muscles. MRI tractography, mainly known as a tool for visualisation and characterisation of white matter fibers in the brain via the acquisition of DTI (Diffusion Tensor Imaging) sequences, could be an interesting tool to visualize in 3D the structure of pelvic sphincters and their lesions. It may thereby establish the link with observed dysfunctions, thus potentially providing a complement to the urological and proctographic examinations already carried out.
Some studies have already shown that MRI is an ideal method for visualizing pelvic floor muscle fibers in women. As far as it is known, there are no studies in the literature on pelvic sphincter tractography. The objective is, first, to define from this initial study the sensitivity of the method for the visualization of the pelvic sphincters architecture regardless of the gender. In a second time, it will give a description of normal and abnormal (pathological cases) tractography, as well as a descriptive post-surgery. The results found in each of these situations can be compared in order to evaluate the sensitivity and contribution of MRI tractography for the diagnosis of pelvic sphincter dysfunctions and their management, as well as to evaluate the impact of surgery.
The other interest of this study is the inclusion of both patients consulting for a simple diagnosis and those coming for a pre- and post-operative examination. This will allow the assessment of the information provided by pelvic sphincters tractography on a panel of various and frequently encountered situations in clinical routine at the IHU.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pelvic MRI
This arm involves patients undergoing a pelvic MRI.
At the end of the planned sequence, but before any contrast agent injection:
* Acquisition of a an additional anatomical T2 SPACE sequence
* Acquisition of a tractography Diffusion Tensor Imaging (DTI) sequence All acquisitions will be done in an acceptable duration (less than 45 minutes)
MRI with DTI sequence
At the end of the planned sequence, but before any contrast agent injection:
* Acquisition of a an additional anatomical T2 SPACE sequence
* Acquisition of a tractography DTI sequence
Pelvic surgery
This arm involves patients undergoing a pelvic surgery and coming for a postoperative MRI. An additional MRI is performed before the surgery and additional sequences are added to the planned postoperative MRI, at the end of the planned sequence, but before any contrast agent injection:
* Acquisition of a an additional anatomical T2 SPACE sequence
* Acquisition of a tractography Diffusion Tensor Imaging (DTI) sequence All acquisitions will be done in an acceptable duration (less than 45 minutes)
MRI with DTI sequence
At the end of the planned sequence, but before any contrast agent injection:
* Acquisition of a an additional anatomical T2 SPACE sequence
* Acquisition of a tractography DTI sequence
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
MRI with DTI sequence
At the end of the planned sequence, but before any contrast agent injection:
* Acquisition of a an additional anatomical T2 SPACE sequence
* Acquisition of a tractography DTI sequence
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient able to receive and understand information related to the study and give written informed consent
3. Patient affiliated to the French social security system
4. Patient undergoing a pelvic MRI examination whose result at the end of the T2 sequences in the 3 section planes shows the absence of pathology or a distant pathology that does not affect the pelvic sphincters OR Patient undergoing a pelvic surgery including fistula treatment, abscess treatment, sigmoid mucosectomy or rectal mucosectomy
Exclusion Criteria
2. Patient with hip prostheses
3. Patient with contraindications to MRI:
* pacemaker or automatic defibrillator, pump
* implanted
* auditory, anal, painkiller neurostimulator, etc ...
* ferromagnetic bodies in soft tissues, body
* intraocular foreigners, cerebrovascular clips
* claustrophobia
4. Patient presenting, in the judgment of the investigator, an illness that may prevent participation in the procedures provided by the study
5. Pregnant or lactating patient
6. Patient in exclusion period (determined by a previous or a current study)
7. Patient under guardianship or trusteeship
8. Patient under the protection of justice
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
IHU Strasbourg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Catherine ROY, MD
Role: PRINCIPAL_INVESTIGATOR
Service de Radiologie et d'Echographie, NHC Strasbourg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Radiologie et d'Echographie, NHC Strasbourg
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zijta FM, Froeling M, van der Paardt MP, Lakeman MM, Bipat S, van Swijndregt AD, Strijkers GJ, Nederveen AJ, Stoker J. Feasibility of diffusion tensor imaging (DTI) with fibre tractography of the normal female pelvic floor. Eur Radiol. 2011 Jun;21(6):1243-9. doi: 10.1007/s00330-010-2044-8. Epub 2011 Jan 1.
Zijta FM, Lakeman MM, Froeling M, van der Paardt MP, Borstlap CS, Bipat S, Montauban van Swijndregt AD, Strijkers GJ, Roovers JP, Nederveen AJ, Stoker J. Evaluation of the female pelvic floor in pelvic organ prolapse using 3.0-Tesla diffusion tensor imaging and fibre tractography. Eur Radiol. 2012 Dec;22(12):2806-13. doi: 10.1007/s00330-012-2548-5. Epub 2012 Jul 14.
Rousset P, Delmas V, Buy JN, Rahmouni A, Vadrot D, Deux JF. In vivo visualization of the levator ani muscle subdivisions using MR fiber tractography with diffusion tensor imaging. J Anat. 2012 Sep;221(3):221-8. doi: 10.1111/j.1469-7580.2012.01538.x. Epub 2012 Jul 4.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
18-005
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.